Abstract
Contemporary hormonal contraception formulations contain lower doses of estrogen, have new synthetic progestin components, and provide novel methods of delivery that have not been studied extensively in relation to breast cancer risk. Given that hormonal contraception is the leading method of birth control in the United States, it is important to reevaluate risk using current formulations. Recent studies including contemporary hormonal contraception formulations will be described.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 224-226 |
| Number of pages | 3 |
| Journal | American Journal of Lifestyle Medicine |
| Volume | 12 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 1 2018 |
All Science Journal Classification (ASJC) codes
- Medicine (miscellaneous)
- Health Policy
- Public Health, Environmental and Occupational Health